Pulmonary Adenosquamous Carcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pulmonary Adenosquamous Carcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 2

NCT02133196

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

Background: The NCI Surgery Branch has developed an experimental therapy that involves taking white blood cells from patients' tumors, growing them in the labo…

United States85 participantsStarted 2014-10-23

Treatment: Aldesleukin, Fludarabine

RecruitingPhase 1

NCT07454642

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

This is a first-in-human (FIH), Phase 1 open-label, multicenter dose escalation study investigating AVA6103 monotherapy administered intravenously in patients w…

United States144 participantsStarted 2026-03

Treatment: AVA6103

All recent trials (83 shown)

Active — Not RecruitingPhase 1

NCT03132922

MAGE-A4ᶜ¹º³²T for Multi-Tumor

This study will investigate the safety and tolerability of MAGE-A4ᶜ¹º³²T cell therapy in subjects who have the appropriate HLA-A2 tissue marker and whose urinar…

United States71 participantsStarted 2017-05-15

Treatment: Autologous genetically modified MAGE-A4ᶜ¹º³²T cells, Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation

Active — Not RecruitingPhase 2

NCT00334815

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-sma…

This clinical trial studies combination chemotherapy, radiation therapy, and bevacizumab in treating patients with newly diagnosed stage III non-small cell lung…

United States29 participantsStarted 2006-06-15

Treatment: Bevacizumab, Cisplatin

Pulmonary Adenosquamous Carcinoma

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

All recent trials (83 shown)

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-sma…

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

All recent trials (83 shown)

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-sma…

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanc…

Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemother…

Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small…

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China

Icotinib for Completed Resected IB NSCLC With EGFR Mutation

Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy

Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer

Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients

Almonertinib as First-line Treatment in Patients With EGFR+ Positive Pulmonary Adenosquamous Carcinoma or Combined Adeno…

Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer

Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Ce…

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung…